Kuriakose Emil's Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Jan 6, 2026
- Accession no.
- 0001892413-26-000002
- Filed
- Jan 6, 2026
- Trade date
- Jan 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $44.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kuriakose EmilCIK 0001892413 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | SSaleDisposed | −200 | $39.60 | −$7,920 | 51,320 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −955 | $38.36 | −$36,633.8 | 50,365 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.